. Randomized trial of verubecestat for mild-to-moderate Alzheimer’s disease. N Engl J Med. 2018 May 2.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

News

  1. Paper Alert: Verubecestat EPOCH Findings Published

Therapeutics

  1. Verubecestat